Search by Drug Name or NDC
NDC 66869-0564-90 SEGLENTIS 56; 44 mg/1; mg/1 Details
SEGLENTIS 56; 44 mg/1; mg/1
SEGLENTIS is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is CELECOXIB; TRAMADOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Celecoxib is used to relieve pain, tenderness, swelling and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), and ankylosing spondylitis (arthritis that mainly affects the spine). Celecoxib is also used to treat juvenile rheumatoid arthritis (a type of arthritis that affects children) in children 2 years of age and older. Celecoxib is also used to treat painful menstrual periods and to relieve other types of short-term pain including pain caused by injuries, surgery and other medical or dental procedures, or medical conditions that last for a limited time. Celecoxib is in a class of NSAIDs called COX-2 inhibitors. It works by stopping the body's production of a substance that causes pain and inflammation.
Related Packages: 66869-0564-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Celecoxib
Tramadol is used to relieve moderate to moderately severe pain. Tramadol extended-release tablets and capsules are only used by people who are expected to need medication to relieve pain around-the-clock. Tramadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 66869-0564-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tramadol
Product Information
| NDC | 66869-0564 |
|---|---|
| Product ID | 66869-564_badd15b0-400a-4f3a-bf2d-e3d4b87b2348 |
| Associated GPIs | 65995002100320 |
| GCN Sequence Number | 082830 |
| GCN Sequence Number Description | tramadol HCl/celecoxib TABLET 44 MG-56MG ORAL |
| HIC3 | H3N |
| HIC3 Description | OPIOID ANALGESIC AND NSAID COMBINATION |
| GCN | 51517 |
| HICL Sequence Number | 047670 |
| HICL Sequence Number Description | TRAMADOL HCL/CELECOXIB |
| Brand/Generic | Brand |
| Proprietary Name | SEGLENTIS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | celecoxib and tramadol hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 56; 44 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CELECOXIB; TRAMADOL HYDROCHLORIDE |
| Labeler Name | Kowa Pharmaceuticals America, Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Full Opioid Agonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA213426 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66869-0564-90 (66869056490)
| NDC Package Code | 66869-564-90 |
|---|---|
| Billing NDC | 66869056490 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (66869-564-90) / 90 TABLET in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 4.35147 |
| Pricing Unit | EA |
| Effective Date | 2023-04-19 |
| NDC Description | SEGLENTIS 56 MG-44 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |